Kết quả tìm kiếm - Elizabeth L. Lockerman
- Đang hiển thị 1 - 15 kết quả của 15
-
1
-
2
The Allelic Context of the C797S Mutation Acquired upon Treatment with Third-Generation EGFR Inhibitors Impacts Sensitivity to Subsequent Treatment Strategies Bằng Matthew J. Niederst, Haichuan Hu, Hillary E. Mulvey, Elizabeth L. Lockerman, Angel R. Garcia, Zofia Piotrowska, Lecia V. Sequist, Jeffrey A. Engelman
Được phát hành 2015Artigo -
3
Inhibition of mutant EGFR in lung cancer cells triggers SOX2-FOXO6-dependent survival pathways Bằng S. Michael Rothenberg, Kyle Concannon, Sarah Cullen, Gaylor Boulay, Alexa B. Turke, Anthony C. Faber, Elizabeth L. Lockerman, Miguel N. Rivera, Jeffrey A. Engelman, Shyamala Maheswaran, Daniel A. Haber
Được phát hành 2015Artigo -
4
Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib Bằng Ryohei Katayama, Luc Friboulet, Sumie Koike, Elizabeth L. Lockerman, Tahsin M. Khan, Justin F. Gainor, A. John Iafrate, Kengo Takeuchi, Makoto Taiji, Yasushi Okuno, Naoya Fujita, Jeffrey A. Engelman, Alice T. Shaw
Được phát hành 2014Artigo -
5
CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors Bằng Sadhna Vora, Dejan Juric, Nayoon Kim, Mari Mino‐Kenudson, Tiffany G. Huynh, Carlotta Costa, Elizabeth L. Lockerman, Sarah F. Pollack, Manway Liu, Xiaoyan Li, Joseph Lehár, Marion Wiesmann, Markus Wartmann, Yan Chen, Z. Alexander Cao, Maria Pinzon-Ortiz, Sunkyu Kim, Robert Schlegel, Alan Huang, Jeffrey A. Engelman
Được phát hành 2014Artigo -
6
Acquired Resistance to Crizotinib from a Mutation in <i>CD74</i>–<i>ROS1</i> Bằng Mark M. Awad, Ryohei Katayama, Michele McTigue, Wei Liu, Yali Deng, Alexei Brooun, Luc Friboulet, Donghui Huang, Matthew D. Falk, Sergei Timofeevski, Keith D. Wilner, Elizabeth L. Lockerman, Tahsin M. Khan, Sidra Mahmood, Justin F. Gainor, Subba R. Digumarthy, James R. Stone, Mari Mino‐Kenudson, James G. Christensen, A. John Iafrate, Jeffrey A. Engelman, Alice T. Shaw
Được phát hành 2013Artigo -
7
Heterogeneity Underlies the Emergence of <i>EGFR</i>T790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor Bằng Zofia Piotrowska, Matthew J. Niederst, Chris Karlovich, Heather A. Wakelee, Joel W. Neal, Mari Mino‐Kenudson, Linnea Fulton, Aaron N. Hata, Elizabeth L. Lockerman, Anuj Kalsy, Subba R. Digumarthy, Alona Muzikansky, Mitch Raponi, Angel R. Garcia, Hillary E. Mulvey, Melissa Parks, Richard H. DiCecca, Dora Dias‐Santagata, A. John Iafrate, Alice T. Shaw, Andrew R. Allen, Jeffrey A. Engelman, Lecia V. Sequist
Được phát hành 2015Artigo -
8
The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer Bằng Luc Friboulet, Nanxin Li, Ryohei Katayama, Christian C. Lee, Justin F. Gainor, Adam S. Crystal, Pierre‐Yves Michellys, Mark M. Awad, Noriko Yanagitani, Sung Joon Kim, AnneMarie Culazzo Pferdekamper, Jie Li, Shailaja Kasibhatla, Frank F. Sun, Xiuying Sun, Su Hua, Peter McNamara, Sidra Mahmood, Elizabeth L. Lockerman, Naoya Fujita, Makoto Nishio, Jennifer L. Harris, Alice T. Shaw, Jeffrey A. Engelman
Được phát hành 2014Artigo -
9
Patient-derived models of acquired resistance can identify effective drug combinations for cancer Bằng Adam S. Crystal, Alice T. Shaw, Lecia V. Sequist, Luc Friboulet, Matthew J. Niederst, Elizabeth L. Lockerman, Rosa L. Frias, Justin F. Gainor, Arnaud Amzallag, Patricia Greninger, Dana Lee, Anuj Kalsy, María Gomez‐Caraballo, Leila Elamine, Emily Howe, Wooyoung Hur, Eugene Lifshits, Hayley Robinson, Ryohei Katayama, Anthony C. Faber, Mark M. Awad, Sridhar Ramaswamy, Mari Mino‐Kenudson, A. John Iafrate, Cyril H. Benes, Jeffrey A. Engelman
Được phát hành 2014Artigo -
10
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer Bằng Matthew J. Niederst, Lecia V. Sequist, John T. Poirier, Craig H. Mermel, Elizabeth L. Lockerman, Angel R. Garcia, Ryohei Katayama, Carlotta Costa, Kenneth N. Ross, Teresa Morán, Emily Howe, Linnea Fulton, Hillary E. Mulvey, Lindsay A. Bernardo, Farhiya Mohamoud, Norikatsu Miyoshi, Paul A. VanderLaan, Daniel B. Costa, Pasi A. Jänne, Darrell R. Borger, Sridhar Ramaswamy, Toshi Shioda, A. John Iafrate, Gad Getz, Charles M. Rudin, Mari Mino‐Kenudson, Jeffrey A. Engelman
Được phát hành 2015Artigo -
11
Clinical Acquired Resistance to RAF Inhibitor Combinations in <i>BRAF</i>-Mutant Colorectal Cancer through MAPK Pathway Alterations Bằng Leanne G. Ahronian, Erin M. Sennott, Eliezer M. Van Allen, Nikhil Wagle, Eunice L. Kwak, Jason E. Faris, Jason T. Godfrey, Koki Nishimura, Kerry D. Lynch, Craig H. Mermel, Elizabeth L. Lockerman, Anuj Kalsy, Joseph M. Gurski, Samira Bahl, Kristin Anderka, Lisa M. Green, Niall J. Lennon, Tiffany G. Huynh, Mari Mino‐Kenudson, Gad Getz, Dora Dias‐Santagata, A. John Iafrate, Jeffrey A. Engelman, Levi A. Garraway, Ryan B. Corcoran
Được phát hành 2015Artigo -
12
EGF816 Exerts Anticancer Effects in Non–Small Cell Lung Cancer by Irreversibly and Selectively Targeting Primary and Acquired Activating Mutations in the EGF Receptor Bằng Yong Jia, Jose Juarez, Jie Li, Mari Manuia, Matthew J. Niederst, Celin Tompkins, Noelito Timple, Mei-Ting Vaillancourt, AnneMarie Culazzo Pferdekamper, Elizabeth L. Lockerman, Chun Li, Jennifer M. Anderson, Carlotta Costa, Debbie Liao, Eric A. Murphy, Michael DiDonato, Badry Bursulaya, G. Lelais, Jordi Barretina, Matthew McNeill, Robert Epple, Thomas H. Marsilje, Nazima Pathan, Jeffrey A. Engelman, Pierre‐Yves Michellys, Peter McNamara, Jennifer L. Harris, Steven L. Bender, Shailaja Kasibhatla
Được phát hành 2016Artigo -
13
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition Bằng Aaron N. Hata, Matthew J. Niederst, Hannah L. Archibald, María Gomez‐Caraballo, Faria M. Siddiqui, Hillary E. Mulvey, Yosef E. Maruvka, Fei Ji, Hyo-Eun Carrie Bhang, Viveksagar Krishnamurthy Radhakrishna, Giulia Siravegna, Haichuan Hu, Sana Raoof, Elizabeth L. Lockerman, Anuj Kalsy, Dana Lee, Celina L Keating, David A. Ruddy, Leah J. Damon, Adam S. Crystal, Carlotta Costa, Zofia Piotrowska, Alberto Bardelli, A. John Iafrate, Ruslan I. Sadreyev, Frank Stegmeier, Gad Getz, Lecia V. Sequist, Anthony C. Faber, Jeffrey A. Engelman
Được phát hành 2016Artigo -
14
Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM Bằng Kyung-A Song, Matthew J. Niederst, Timothy L. Lochmann, Aaron N. Hata, Hidenori Kitai, Jungoh Ham, Konstantinos V. Floros, Mark Hicks, Haichuan Hu, Hillary E. Mulvey, Yotam Drier, Daniel A.R. Heisey, Mark T. Hughes, Neha U. Patel, Elizabeth L. Lockerman, Angel E. Garcı́a, Shawn Gillepsie, Hannah L. Archibald, María Gomez‐Caraballo, Tara J. Nulton, Brad E. Windle, Zofia Piotrowska, Sinem E. Sahingur, Shirley M. Taylor, Mikhail G. Dozmorov, Lecia V. Sequist, B Bernstein, Hiromichi Ebi, Jeffrey A. Engelman, Anthony C. Faber
Được phát hành 2017Artigo -
15
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in<i>ALK</i>-Rearranged Lung Cancer Bằng Justin F. Gainor, Leila Dardaei, Satoshi Yoda, Luc Friboulet, Ignaty Leshchiner, Ryohei Katayama, Ibiayi Dagogo‐Jack, Shirish M. Gadgeel, Katherine R. Schultz, Manrose Singh, Emily Chin, Melissa Parks, Dana Lee, Richard H. DiCecca, Elizabeth L. Lockerman, Tiffany G. Huynh, Jennifer Logan, Lauren L. Ritterhouse, Long P. Le, Ashok Muniappan, Subba R. Digumarthy, Colleen L. Channick, Colleen Keyes, Gad Getz, Dora Dias‐Santagata, Rebecca S. Heist, Jochen K. Lennerz, Lecia V. Sequist, Cyril H. Benes, A. John Iafrate, Mari Mino‐Kenudson, Jeffrey A. Engelman, Alice T. Shaw
Được phát hành 2016Artigo
Công cụ tìm kiếm:
Các môn học liên quan
Biology
Cancer research
Medicine
Cancer
Internal medicine
Gene
Lung cancer
Genetics
Oncology
Mutation
Epidermal growth factor receptor
Malignant pleural effusion
Mutant
Anaplastic lymphoma kinase
Crizotinib
ALK inhibitor
EGFR inhibitors
Receptor
Adenocarcinoma
Ceritinib
Chemistry
Gefitinib
Pharmacology
Signal transduction
Alectinib
Biochemistry
Cell
Cell biology
Colorectal cancer
Drug resistance